Lymphoid neoplasm
MONDO:0005157A neoplasm composed of a lymphocytic cell population which is usually malignant (clonal) by molecular genetic and/or immunophenotypic analysis. Lymphocytic neoplasms include Hodgkin and non-Hodgkin lymphomas, acute and chronic lymphocytic leukemias, and plasma cell neoplasms.
Also known as: lymphocytic and plasma cell neoplasm, lymphocytic and plasma cell tumor, lymphocytic and plasma cell tumour, lymphocytic and plasmacytic neoplasm, lymphocytic neoplasm, lymphocytic tumor, lymphocytic tumour, lymphoid and plasma cell tumor
5948 clinical trials for this condition and its sub-types, 11 tagged with Lymphoid neoplasm itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Lymphoid neoplasm
-
Lymphoma 606 trials · 4,243 incl. sub-types
27 sub-types
- B-cell neoplasm 304 trials · 3,167 incl. sub-types Sub-types →
- Non-Hodgkin lymphoma 526 trials · 2,897 incl. sub-types Sub-types →
- Primary organ-specific lymphoma 0 trials · 329 incl. sub-types Sub-types →
- Hodgkins lymphoma 262 trials · 326 incl. sub-types Sub-types →
- Mediastinal malignant lymphoma 6 trials · 180 incl. sub-types Sub-types →
- Pediatric lymphoma 3 trials · 141 incl. sub-types Sub-types →
- Peripheral T-cell lymphoma, not otherwise specified 61 trials
- Extranodal nasal NK/T cell lymphoma 51 trials
- Adult lymphoma 1 trial · 33 incl. sub-types Sub-types →
- Eye lymphoma 0 trials · 16 incl. sub-types Sub-types →
- B-cell lymphoma, unclassifiable, with features intermediate between diffuse large b-cell lymphoma and classical Hodgkin lymphoma 11 trials · 12 incl. sub-types Sub-types →
- Gastrointestinal lymphoma 0 trials · 7 incl. sub-types Sub-types →
- Composite lymphoma 5 trials
- AIDS-related primary central nervous system lymphoma 3 trials
- Breast lymphoma 0 trials · 1 incl. sub-types Sub-types →
- Heart lymphoma 1 trial
- Bladder lymphoma 0 trials
- Chest wall lymphoma 0 trials Sub-types →
- Lung lymphoma 0 trials Sub-types →
- Methotrexate-associated lymphoproliferative disorders 0 trials
- Nasal cavity lymphoma 0 trials
- Ovarian lymphoma 0 trials
- Progressive transformation of germinal centers 0 trials
- Prostate lymphoma 0 trials
- Retroperitoneal lymphoma 0 trials
- Tracheal lymphoma 0 trials
- Ureteral lymphoma 0 trials
-
Lymphoid leukemia 23 trials · 1,360 incl. sub-types
3 sub-types
- Acute lymphoblastic leukemia 507 trials · 1,317 incl. sub-types Sub-types →
- T-cell leukemia 9 trials · 137 incl. sub-types Sub-types →
- T-cell large granular lymphocyte leukemia 18 trials
-
Precursor lymphoblastic lymphoma/leukemia 12 trials · 1,342 incl. sub-types
4 sub-types
- Acute lymphoblastic leukemia 507 trials · 1,317 incl. sub-types Sub-types →
- Lymphoblastic lymphoma 78 trials · 104 incl. sub-types Sub-types →
- T lymphoblastic leukemia/lymphoma 18 trials · 100 incl. sub-types Sub-types →
- B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality 0 trials · 59 incl. sub-types Sub-types →
-
Neoplasm of immature B and T cells 0 trials · 1,317 incl. sub-types
1 sub-type
- Acute lymphoblastic leukemia 507 trials · 1,317 incl. sub-types Sub-types →
-
T-cell and NK-cell neoplasm 8 trials · 324 incl. sub-types
2 sub-types
- Neoplasm of mature T-cells or NK-cells 4 trials · 248 incl. sub-types Sub-types →
- T lymphoblastic leukemia/lymphoma 18 trials · 100 incl. sub-types Sub-types →
-
Malignant lymphatic vessel tumor 0 trials
Most studied deeper sub-types
-
Double-Drug attack on Hard-to-Treat lymphomas
Disease control Stopped earlyResearchers are testing whether combining two chemotherapy drugs, pralatrexate and romidepsin, is safe and effective for people with lymphoid cancers that have returned or stopped responding to treatment. The trial first finds the highest dose people can tolerate, then gives that…
Phase 1/2 • Sponsor: Jennifer Amengual • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Targeted drug combo shows promise in blood cancer transplant study
Disease control Stopped earlyThis study tested whether adding the targeted drug inotuzumab ozogamicin before and after a stem cell transplant could help control leukemia and lymphoma. It included 15 people aged 12 to 75 with certain blood cancers. The study was stopped early, but researchers looked at safety…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Cancer drug trial halted early – what happened?
Disease control Stopped earlyThis phase 2 trial tested the drug futibatinib in 115 people with advanced solid tumors or blood cancers that have specific FGFR gene changes. The goal was to see if the drug could shrink tumors or cause remission. The study was terminated early, so final results are not yet clea…
Phase 2 • Sponsor: Taiho Oncology, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC